CD44 and cancer: While CD44 expression is almost undetectable on normal ovarian surface epithelium (47, 228, 229), the majority of epithelial ovarian carcinomas demonstrate high CD44 levels (38–40), which is correlated with disease progression, cancer stemness and resistance to therapy (44, 48, 55).